TY - JOUR
T1 - Four year follow-up of a case of fucosidosis treated with unrelated donor bone marrow transplantation
AU - Miano, M.
AU - Lanino, E.
AU - Gatti, R.
AU - Morreale, G.
AU - Fondelli, P.
AU - Celle, M. E.
AU - Stroppiano, M.
AU - Crescenzi, F.
AU - Dini, G.
PY - 2001
Y1 - 2001
N2 - Fucosidosis is a rare autosomal recessive lysosomal disorder caused by α-fucosidase deficiency. We report a child with fucosidosis, second daughter of non-consanguineous parents, for whom biochemical diagnosis followed clinical evidence of the disease in her older sister. Based on previous experiences, the indication to transplant was considered. Since she lacked a matched sibling, an unrelated marrow donor was found. At prehematopoietic stem cell transplantation evaluation, first signs of neurological involvement were clinically detectable. MRI showed diffuse hypomyelination and auditory brainstem responses and somatic-sensorial evoked potentials were altered. Visual evoked potentials were normal, tortuosity in the retinal veins and peripapillary hemorrhages were detected. Bone marrow transplantation conditioning was with a regimen of busulphan, thiotepa and cyclophosphamide; in vivo Campath 1G, cyclosporin A and short course methotrexate were given to prevent graft-versus-host disease. The patient engrafted rapidly and her post-transplant course was complicated by moderate graft-versus-host disease, transient episodes of idiopathic thrombocytopenic purpura, repeated septic complications and recurrent episodes of Sweet's syndrome. Sequential short tandem repeat polymorphisms on peripheral blood and bone marrow cells documented the persistence of donor engraftment. Follow-up showed a progressive rise of enzymatic levels. Psychomotor development improved, as confirmed by evaluation of evoked potentials and by MRI scanning.
AB - Fucosidosis is a rare autosomal recessive lysosomal disorder caused by α-fucosidase deficiency. We report a child with fucosidosis, second daughter of non-consanguineous parents, for whom biochemical diagnosis followed clinical evidence of the disease in her older sister. Based on previous experiences, the indication to transplant was considered. Since she lacked a matched sibling, an unrelated marrow donor was found. At prehematopoietic stem cell transplantation evaluation, first signs of neurological involvement were clinically detectable. MRI showed diffuse hypomyelination and auditory brainstem responses and somatic-sensorial evoked potentials were altered. Visual evoked potentials were normal, tortuosity in the retinal veins and peripapillary hemorrhages were detected. Bone marrow transplantation conditioning was with a regimen of busulphan, thiotepa and cyclophosphamide; in vivo Campath 1G, cyclosporin A and short course methotrexate were given to prevent graft-versus-host disease. The patient engrafted rapidly and her post-transplant course was complicated by moderate graft-versus-host disease, transient episodes of idiopathic thrombocytopenic purpura, repeated septic complications and recurrent episodes of Sweet's syndrome. Sequential short tandem repeat polymorphisms on peripheral blood and bone marrow cells documented the persistence of donor engraftment. Follow-up showed a progressive rise of enzymatic levels. Psychomotor development improved, as confirmed by evaluation of evoked potentials and by MRI scanning.
KW - Fucosidosis
KW - Hematopoietic stem cell transplantation
KW - Inborn errors
UR - http://www.scopus.com/inward/record.url?scp=0035029829&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035029829&partnerID=8YFLogxK
U2 - 10.1038/sj.bmt.1702994
DO - 10.1038/sj.bmt.1702994
M3 - Article
C2 - 11360116
AN - SCOPUS:0035029829
SN - 0268-3369
VL - 27
SP - 747
EP - 751
JO - Bone Marrow Transplantation
JF - Bone Marrow Transplantation
IS - 7
ER -